Trinity Bio Ownership

TRIB
 Stock
  

USD 1.41  0.01  0.71%   

Some institutional investors establish a significant position in stocks such as Trinity Bio in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Trinity Bio, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Additionally, take a look at World Market Map.
  
Trinity Bio ADR shows a total of twenty million nine hundred thousand outstanding shares. 30% of Trinity Bio ADR outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulation than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or about to change. Please note that no matter how much assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.

Trinity Stock Ownership Analysis

About 43.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.38. Trinity Bio ADR last dividend was issued on the 5th of June 2015. The entity had 1:4 split on the 2nd of June 2005. Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market in the Americas, Africa, Asia, and Europe. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland. Trinity Bio operates under Pharmaceuticals And Biosciences classification in the United States and is traded on NASDAQ Exchange. It employs 477 people. To find out more about Trinity Bio ADR contact the company at 353 1 276 9800 or learn more at https://www.trinitybiotech.com.

Trinity Bio Investors Sentiment

The influence of Trinity Bio's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Trinity. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Trinity Bio Implied Volatility

    
  290.72  
Trinity Bio's implied volatility exposes the market's sentiment of Trinity Bio ADR stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Trinity Bio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Trinity Bio stock will not fluctuate a lot when Trinity Bio's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Trinity Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Trinity Bio's short interest history, or implied volatility extrapolated from Trinity Bio options trading.

Currently Active Assets on Macroaxis

Additionally, take a look at World Market Map. Note that the Trinity Bio ADR information on this page should be used as a complementary analysis to other Trinity Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Trinity Stock analysis

When running Trinity Bio ADR price analysis, check to measure Trinity Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trinity Bio is operating at the current time. Most of Trinity Bio's value examination focuses on studying past and present price action to predict the probability of Trinity Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Trinity Bio's price. Additionally, you may evaluate how the addition of Trinity Bio to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Is Trinity Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Bio. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trinity Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.77
Market Capitalization
53.7 M
Quarterly Revenue Growth YOY
-0.27
Return On Assets
0.031
Return On Equity
-1.91
The market value of Trinity Bio ADR is measured differently than its book value, which is the value of Trinity that is recorded on the company's balance sheet. Investors also form their own opinion of Trinity Bio's value that differs from its market value or its book value, called intrinsic value, which is Trinity Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trinity Bio's market value can be influenced by many factors that don't directly affect Trinity Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trinity Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Trinity Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.